Christopher Simon - 30 May 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
President & CEO, Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Issuer symbol
HAE
Transactions as of
30 May 2025
Transactions value $
-$1,820,115
Form type
4
Filing time
03 Jun 2025, 16:41:44 UTC
Previous filing
27 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simon, Christopher President & CEO, Director 125 SUMMER STREET, BOSTON /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon 03 Jun 2025 0001674993

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award $0 +66.7K +19.89% $0.00 402K 30 May 2025 Direct F1, F2
transaction HAE Common Stock Tax liability -$1.82M -26.2K -6.53% $69.38 376K 30 May 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025.
F2 This number includes unvested restricted stock units ("RSUs") previously reported.
F3 Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.